01/07/2015 - 10:18am

Teva Pharmaceutical on Tuesday announced the Food and Drug Administration approved the launch of the company's valsartan tablets, the generic version of Diovan tablets from Novartis. 

 

01/06/2015 - 2:09pm

Vermont Attorney General Bill Sorrell is investigating generic drug price inflation.

01/05/2015 - 3:24pm

The Consumer Healthcare Products Association thanked President Obama for signing the Designer Anabolic Steroid Control Act into law last month.

12/30/2014 - 11:17am

Vertex Pharmaceuticals has announced that the Food and Drug Administration approved a supplemental new drug application for the use of Kalydeco (ivacaftor) in people with cystic fibrosis ages 6 years and older who have the R117H mutation in the cystic fibrosis transmembrane conductance regulator gene.

12/29/2014 - 11:26am

Genentech last week announced that the Food and Drug Administration approved a supplemental biologics license application for Gazyva to be used in combination with chlorambucil chemotherapy in people with previously untreated chronic lymphocytic leukemia.

12/29/2014 - 10:46am

In a staff memo, the Office of Generics Drug’s acting director, Kathleen Uhl, vowed to take action on 90% of the abbreviated new drug application backlog before October 2017, and has appointed Ted Sherwood as acting director of OGD’s Office of Regulatory Operations to help with the improvements, FDANews.com has reported.

12/29/2014 - 10:29am

Novo Nordisk last week announced that the Food and Drug Administration approved the company's new drug application for Saxenda, a once-daily glucagon-like peptide-1 receptor agonist used as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adults.

12/18/2014 - 3:10pm

As out-of-pocket expenses rise, many Americans say that the affordability of basic medical care is a hardship and, as a result, some are forgoing treatment because they are worried about cost, according to a recent national poll conducted by The New York Times and CBS News.

12/18/2014 - 11:59am

The U.S. Senate Special Committee on Aging unveiled a new bipartisan report earlier this week that focuses on ways to increase the use of generic drugs within the Medicare Part D program.